Have a personal or library account? Click to login
Congenital Primary Pachydermoperiostosis and Striate Palmoplantar Keratoderma - a Case Report Cover

Congenital Primary Pachydermoperiostosis and Striate Palmoplantar Keratoderma - a Case Report

Open Access
|Dec 2014

References

  1. 1. Castori M, Sinibaldi L, Mingarelli R, Lachman RS, Rimoin DL, Dallapiccola B. Pachydermoperiostosis: an update. Clin Genet 2005;68:477-86.10.1111/j.1399-0004.2005.00533.x16283874
  2. 2. Irvine AD, Mellerio JE. Genetics and genodermatoses. In: Burns T, Breathnach S, Cox N, Griffi th SC, editors. Rook’s textbook of dermatology. 8th ed. Oxford: Blackwel Publishing; 2010. p. 15.1-97.10.1002/9781444317633.ch15
  3. 3. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008;40(6):789-93.10.1038/ng.15318500342
  4. 4. Martínez-Ferrer, Peris P, Alós L, Morales-Ruiz M, Guanabens N. Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report. Clin Rheumatol 2009;28:1229-33.10.1007/s10067-009-1197-919455364
  5. 5. Gómez Rodríguez N, IbánezRuán J, González Pérez M. Primary hypertrophic osteoarthropathy (pachydermoperiostosis). Report of two familial cases and literature review. Rheumatol Clin 2009;5(6):259-63.
  6. 6. Bergmann C, Wobser M, Morbach H, Falkenbach A, Wittenhagen D, Lassay L, et al. Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15- PGHD/HPGD loss-of-function mutations. Exp Dermatol 2011;20:531-3.10.1111/j.1600-0625.2011.01248.x21426412
  7. 7. Dabir T, Sills AM, Hall CM, et al. Cranio-osteoarthropathy in sibs. Clin Dysmorphol 2007;16:197-201.10.1097/MCD.0b013e32801470d817551338
  8. 8. Yüksel-Konuk B, Sırmacı A, Ayten GE, Özdemir M, Aslan İ, Yılmaz-Turay Ü, et al. Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy. Rheumatol Int 2009;30(1):39-43.10.1007/s00296-009-0895-619306095
  9. 9. Silveira LH, Martinez-Lavin M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000;18: 57-62.
  10. 10. Jajic I, Jajic Z. Prevalence of primary hypertrophic osteoarthropathy in selected population. Clin Exp Rheumatol 1992;10:73.
  11. 11. Rastogi R, Suma GN, Prakash R, Rastogi UC, Bhargava S, Rastogi V, et al. Pachydermoperiostosis or primary hypertrophic osteoarthropathy: a rare clinicoradiologic case. Indian J Radiol Imaging 2009;19(2):123-6.10.4103/0971-3026.50829276517619881067
  12. 12. Okten A, Mungan I, Kalyoncu M, Orbak Z. Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia. Clin Rheumatol 2007; 26: 8-11.10.1007/s10067-005-1161-216738844
  13. 13. Latos-Bielenska A, Marik I, Kuklik M, Materna-Kiryluk A, Povysil C, Kozlowski K. Pachydermoperiostosis-critical analysis with report of fi ve unusual cases. Eur J Pediatr 2007;166:1237-43.10.1007/s00431-006-0407-617285282
  14. 14. Athappan G, Unnikrishnan A, Chengat V, Chandraprakasam S, Arthanareeswaran V, Muthukrishnan S, et al. Touraine Solente Gole syndrome: the disease and associated tongue fi ssuring. Rheumatol Int 2009;29:1091-3.10.1007/s00296-008-0798-y19050893
  15. 15. Ghosn S, Uthman I, Dahdah M, Kibbi AG, Rubeiz N. Treatment of pachydermoperiostosis pachydermia with botulinum toxin type A. J Am Acad Dermatol 2010;63:1036-41. 10.1016/j.jaad.2009.08.06720933299
  16. 16 Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Th iboutot DM. Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. J Clin Invest 2008;118(4):1468-78.10.1172/JCI33869226203018317594
  17. 17. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2000;43:1773-808.
  18. 18. da Costa VF, de Magalhaes Souza Fialho SC, Zimmermann AF, Neves FS, Werner de Castro GR, Pereira IA. Infl iximab treatment in pachydermoperiostosis. J Clin Rheumatol 2010;16(4):183-4.10.1097/RHU.0b013e3181df91c620414127
  19. 19. George L, Sachithanandam K, Gupta A, Pulimood S. Frontal rhytidectomy as surgical treatment for pachydermoperiostosis. J Dermatolog Treat 2008;19(1):61-3.10.1080/0954663070138995518273728
  20. 20. Barraud-Klenovsek MM, Lübbe J, Burg G. Primary digital clubbing associated with palmoplantar keratoderma. Dermatology 1997;194(3):302-5.10.1159/0002461379187857
  21. 21. Perić-Hajzler Z, Kandolf-Sekulović L, Zolotarevski L. Psoriatic onycho-pachydermo-periostitis. Serb J Dermatol Venereol 2010;2(2):54-8. 10.2478/v10249-011-0022-z
Language: English
Page range: 81 - 92
Published on: Dec 11, 2014
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Slobodan Stojanović, Nada Vučković, Marina Jovanović, Kosta Petrović, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.